Stabilized hydrophobic protein formulations of G-CSF

Details Stabilized hydrophobic protein formulations of G-CSF Stabilized hydrophobic protein formulations of G-CSF

1988-12-16

1992-04-14

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Lymphokine

514 2, 514 8, 514 12, 514 21, 514970, 530351, 435 695, 435 6952, 435 696, A61R 3702

Patent

active

051046512

ABSTRACT:
A stable pharmaceutically acceptable formulation containing a pharmaceutically acceptable amount of a protein is disclosed. Also disclosed are associated means and methods for preparing such formulations.

REFERENCES:
patent: 4623717 (1986-11-01), Fernandes et al.
patent: 4645830 (1987-02-01), Yasushi et al.
patent: 4647454 (1987-03-01), Cymbalista
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4810643 (1984-03-01), Souza
patent: 4833127 (1989-05-01), Oho et al.
patent: 4992271 (1991-02-01), Fernandes
Wang et al. J. Parenteral Drug Assoc 1980, vol. 34, pp. 452-462.
Wang et al., J. Parenteral Science & Technology, 1988, vol. 42, pp. 53-526.

Affiliated with

Also associated with

Rating

Stabilized hydrophobic protein formulations of G-CSF does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilized hydrophobic protein formulations of G-CSF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized hydrophobic protein formulations of G-CSF will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2347655